Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [904]
News [1794]
Articles [229]
Editorials [5]
Conferences [136]
elearning [18]
Significant UK variations between hospitals in adverse outcomes for DCIS
Dr Jeremy Thomas - Western General Hospital, Edinburgh, UK
Significant UK variations between hospitals in adverse outcomes for DCIS ( Dr Jeremy Thomas - Western General Hospital, Edinburgh, UK )
1 Apr 2014
EBCC 2014 key messages to doctors
Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK
EBCC 2014 key messages to doctors ( Prof David Cameron - Edinburgh Cancer Centre, Edinburgh, UK )
1 Apr 2014
Comment: Radiotherapy after mastectomy for breast cancer that has spread to...
Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK
Comment: Radiotherapy after mastectomy for breast cancer that has spread to just a few lymph nodes ( Dr Hilary Dobson -  West of Scotland Cancer Network, Glasgow, UK )
1 Apr 2014
Radiotherapy after mastectomy benefit for breast cancer that has spread to just...
Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes ( Dr Paul McGale, Dr Carolyn Taylor, Dr Tim Whelan )
31 Mar 2014
PSA as a marker of disease in patients with prostate cancer and bone metastases
Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal
PSA as a marker of disease in patients with prostate cancer and bone metastases ( Prof Laurence Koltz, Prof Wolfgang Horninger, Prof Bertrand Tombal )
28 Feb 2014
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic...
Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014
The use of abiraterone and enzalutamide against CRPC
Dr Chris Parker and Dr Kurt Miller
The use of abiraterone and enzalutamide against CRPC ( Dr Chris Parker and Dr Kurt Miller )
31 Jan 2014
Latest treatment for CRPC: Combinations, sequencing, radiotherapy and...
Dr Maria De Santis - Kaiser Franz Josef Hospital, Vienna, Austria
Latest treatment for CRPC: Combinations, sequencing, radiotherapy and immunotherapy ( Dr Maria De Santis - Kaiser Franz Josef Hospital, Vienna, Austria )
31 Jan 2014
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant...
Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr...
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer ( Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr John Fitzpatrick )
27 Jan 2014
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)
Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel...
J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion ( J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle )
10 Jan 2014
Symptom management and quality of life in metastatic breast cancer
Dr Polly Niravath - Baylor College of Medicine, Houston, Texas
Symptom management and quality of life in metastatic breast cancer ( Dr Polly Niravath - Baylor College of Medicine, Houston, Texas )
20 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation